Poland· PL-100395053

Dexak 50

A dexketoprofen product containing dexketoprofenum, registered in Poland by InPharm Sp. z o.o.. The same ATC class is registered in 9 of our 19 countries.

ATC M01AE17

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedDexak 50ATCM01AE17REGISTER NO.PL-100395053PACKS LISTED7CHECKEDSeptember 27, 2026

Where it is registered

Dexketoprofen is registered in 9 of 19 countries.

Countries holding a registration under ATC M01AE17 (dexketoprofen), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 5 of them publish a price we can compare per daily dose

Dexketoprofen · ATC M01AE17

9 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Finlandprice
  • Germany
  • Ireland
  • Netherlands
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of dexketoprofen costs, country by country.

Normalised to the WHO defined daily dose (75 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Dexketoprofen · price per daily dose (75 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$2.02
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Dexketoprofenum
Manufacturer
InPharm Sp. z o.o.
Country
Poland (PL)
ATC code
M01AE17
ATC class
Dexketoprofen
Defined daily dose
75 mg, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 7

  • gtin
    05909991348885
  • gtin
    05909991348892
  • gtin
    05909991348908
  • gtin
    05909991348915
  • gtin
    05909991348922
  • gtin
    05909991348939
  • gtin
    05909991348946

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

82 interactions on record for dexketoprofen.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Dexketoprofen · interactions on record

82 records

82 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Dexketoprofen in 10 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All dexketoprofen products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

  • Austria · Ketesse
  • Belgium · Ketesse
  • Bulgaria · Aуксилен, Dexketoprofen-Tchaikapharma
  • Cyprus · Fenodex, Nosatel
  • Czechia · Dekenor, Dexketoprofen Elc
  • Germany · Delprofex, Dexketia
  • Estonia · Dekenor, Dexketoprofen Kalceks
  • Spain · Adoldex, Adolquir Efg
  • Finland · Dexketoprofen Krka, Ketesse
  • France · Ketesse
  • United Kingdom (Northern Ireland) · Keral
  • Greece · Nosatel, Viaxal
  • Croatia · Dekenor, Deksketoprofen Salvus
  • Hungary · Dekenor, Dexoblok
  • Ireland · Keral, Morsadex
  • Italy · Delprofex, Dexfenia
  • Lithuania · Dekenor, Dexketoprofen Kalceks
  • Luxembourg · Ketesse
  • Latvia · Dekenor, Dexketoprofen Kalceks
  • Malta · Fenodex, Keral
  • Netherlands · Stadium
  • Portugal · Dekenor, Dexcetoprofeno Alter
  • Romania · Dekenor, Dexketoprofen Rompharm
  • Slovenia · Dexfenia, Menadex
  • Slovakia · Dexadol, Dexketoprofen Elc

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/fc67f5c1-83ab-4e74-818f-03d0475f23fc
GET /v1/drugs/fc67f5c1-83ab-4e74-818f-03d0475f23fc?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Roztwór do wstrzykiwań / do infuzji",
  "source": "urpl",
  "strength": "50 mg/2 ml",
  "packaging": "05909991348885 ¦ Rp ¦ 124854\n1 amp. 2 ml\n05909991348892 ¦ Rp ¦ 124855\n5 amp. 2 ml\n05909991348908 ¦ Rp ¦ 124856\n6 amp. 2 ml\n05909991348915 ¦ Rp ¦ 124857\n10 amp. 2 ml\n05909991348922 ¦ Rp ¦ 124858\n20 amp. 2 ml\n05909991348939 ¦ Rp ¦ 124859\n50 amp. 2 ml\n05909991348946 ¦ Rp ¦ 124860\n100 amp. 2 ml",
  "substance": "Dexketoprofenum 50 mg/2 ml",
  "common_name": "Dexketoprofenum",
  "pl_product_id": "100395053",
  "pozwolenie_nr": "328/17",
  "auth_procedure": "IR",
  "authorisation_validity": "2027-10-04"
}

See everything about dexketoprofen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.